Control of epistaxis in patients with hereditary hemorrhagic telangiectasia.
Twenty-nine patients were admitted to Pennsylvania Hospital between March 1984 and July 1990 with a diagnosis of epistaxis and hereditary hemorrhagic telangiectasia. Data were obtained through a retrospective review of the charts of these patients. Patients were treated for epistaxis with the CO2 laser, neodymium:aluminum garnet laser with a wavelength of 1064 nm (Nd-Yag), Nd-Yag laser with a wavelength of 532 nm (KTP), septodermoplasty, or any combination of these procedures. Patients underwent an average of 2.5 procedures each. Overall, 25 of 29 patients reported their symptoms had greatly improved with therapy. The average length of time without the need for further surgical intervention was 16.3 months for the Nd-Yag laser and 11.7 months for the KTP laser. Septodermoplasty using buccal mucosal grafts allowed, patients to avoid additional procedures for 24.4 months, which was twice as long as for standard septodermoplasty using split-thickness skin grafts. Although no therapy completely resolves the epistaxis, laser therapy combined with septodermoplasty enables the patients to gain excellent control of the epistaxis for several years.
Siegel
M B
MB
Department of Otolaryngology, Pennsylvania Hospital, Philadelphia 19107.
Keane
W M
WM
Atkins
J F
JF
Rosen
M R
MR
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D004844:Epistaxis / Q000209:etiology / Q000601:surgery*; D005260:Female; D006489:Hemostatic Techniques; D006801:Humans; D053685:Laser Therapy; D008297:Male; D008875:Middle Aged; D009300:Nasal Septum / Q000601:surgery; D012189:Retrospective Studies; D016038:Skin Transplantation; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000150:complications* / Q000601:surgery